About Sen-Jam Pharmaceutical
Sen-Jam Pharmaceutical is a private company based in Huntington, New York. It has reported $480,000 raised in two offerings on Form D since February 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 22, 2023 | Jul 12, 2023amended Jul 25, 2024 | $295,000of $10.0M target | 6 | $49,167 | Equity, Debt, Options, Securities on exercise, Convertible Promissory Notes; Warrants to purchase shares of common stock; Shares of common stock.Rule 506(c) | Form D/A ↗1 earlier filing |
| Jan 28, 2020 | Feb 5, 2020amended Jun 2, 2020 | $185,000of $3.2M target | 5 | $37,000 | Equity, Debt, Securities on exercise, Convertible Promissory Notes. The Notes are convertible into an equity security of the Issuer issued in a future equity offering. The Issuer may waive the minimum investment of $25,000 in its sole discretion.Rule 506(c) | Form D/A ↗1 earlier filing |
| Total, two offerings | $480,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Sen-Jam Pharmaceutical's Form D filed Jul 25, 2024.
JI
Jacqueline Iversen
Executive officer
JI
James Iversen
Executive officer and director